VISIE has successfully demonstrated Continuous Anatomic Auto Tracking (CAAT) for robotic-assisted total knee arthroplasty (RA-TKA).
CAAT is a proprietary technology that gives the power of vision to surgical robotic and navigation systems designed for orthopedic, neuro, cranial and spine surgery, including RA-TKA, a type of robotic-assisted surgery (RAS).
This new capability, which builds upon VISIE’s testing to register the distal femur and proximal tibia to a pre-operative CT scan in a fraction of second, is intended to enable VISIE’s 3D scanners to continuously track the two primary bones that make up the knee joint as they move in space, like they do in RA-TKA.
The company’s goal is for CAAT to allow VISIE’s scanners to move an integrated surgical robotic arm in sync with a knee’s motion during surgery. This would enable VISIE’s scanners to maintain vision of the knee, tracking the anatomy in real time as it moves throughout the surgical procedure.
CAAT holds the promise of pinless RAS for RA-TKA.
VISIE’s team of scientists and hardware and software engineers has been working on technological feasibility for CAAT, knowing the market demand for pinless RAS. “The team keeps realizing breakthrough after breakthrough, and we are ready to shift our efforts to medical device product development and validating this proof of concept when AAHKS is over,” says VISIE’s head of engineering, Michael Landry.
While VISIE has not submitted CAAT to FDA for evaluation, the company is working towards validating performance with the goal of submission.
VISIE has successfully demonstrated Continuous Anatomic Auto Tracking (CAAT) for robotic-assisted total knee arthroplasty (RA-TKA).
CAAT is a proprietary technology that gives the power of vision to surgical robotic and navigation systems designed for orthopedic, neuro, cranial and spine surgery, including RA-TKA, a type of robotic-assisted...
VISIE has successfully demonstrated Continuous Anatomic Auto Tracking (CAAT) for robotic-assisted total knee arthroplasty (RA-TKA).
CAAT is a proprietary technology that gives the power of vision to surgical robotic and navigation systems designed for orthopedic, neuro, cranial and spine surgery, including RA-TKA, a type of robotic-assisted surgery (RAS).
This new capability, which builds upon VISIE’s testing to register the distal femur and proximal tibia to a pre-operative CT scan in a fraction of second, is intended to enable VISIE’s 3D scanners to continuously track the two primary bones that make up the knee joint as they move in space, like they do in RA-TKA.
The company’s goal is for CAAT to allow VISIE’s scanners to move an integrated surgical robotic arm in sync with a knee’s motion during surgery. This would enable VISIE’s scanners to maintain vision of the knee, tracking the anatomy in real time as it moves throughout the surgical procedure.
CAAT holds the promise of pinless RAS for RA-TKA.
VISIE’s team of scientists and hardware and software engineers has been working on technological feasibility for CAAT, knowing the market demand for pinless RAS. “The team keeps realizing breakthrough after breakthrough, and we are ready to shift our efforts to medical device product development and validating this proof of concept when AAHKS is over,” says VISIE’s head of engineering, Michael Landry.
While VISIE has not submitted CAAT to FDA for evaluation, the company is working towards validating performance with the goal of submission.
Copy to clipboard 
